BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 22471498)

  • 1. Cisplatin induces apoptosis via upregulating Wrap53 in U-2OS osteosarcoma cells.
    Yuan JM; Li XD; Liu ZY; Hou GQ; Kang JH; Huang DY; Du SX
    Asian Pac J Cancer Prev; 2011; 12(12):3465-9. PubMed ID: 22471498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bufalin induces apoptosis in osteosarcoma U-2OS and U-2OS methotrexate 300-resistant cell lines in vitro].
    Wang J; Yin JQ; Jia Q; Shen JN; Huang G; Xie XB; Zou CY
    Zhonghua Zhong Liu Za Zhi; 2010 Oct; 32(10):734-8. PubMed ID: 21163061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wrap53, a natural p53 antisense transcript required for p53 induction upon DNA damage.
    Mahmoudi S; Henriksson S; Corcoran M; Méndez-Vidal C; Wiman KG; Farnebo M
    Mol Cell; 2009 Feb; 33(4):462-71. PubMed ID: 19250907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
    Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
    J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic trioxide induces apoptosis of p53 null osteosarcoma MG63 cells through the inhibition of catalase.
    Wang Y; Wei Y; Zhang H; Shi Y; Li Y; Li R
    Med Oncol; 2012 Jun; 29(2):1328-34. PubMed ID: 21308489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. P14ARF sensitizes human osteosarcoma cells to cisplatin-induced apoptosis in a p53-independent manner.
    Yuan XW; Zhu XF; Huang XF; Sheng PY; He AS; Yang ZB; Deng R; Feng GK; Liao WM
    Cancer Biol Ther; 2007 Jul; 6(7):1074-80. PubMed ID: 17611411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bufalin induces apoptosis in human osteosarcoma U-2OS and U-2OS methotrexate300-resistant cell lines.
    Yin JQ; Shen JN; Su WW; Wang J; Huang G; Jin S; Guo QC; Zou CY; Li HM; Li FB
    Acta Pharmacol Sin; 2007 May; 28(5):712-20. PubMed ID: 17439728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crosstalk between the IGF-1R/AKT/mTORC1 pathway and the tumor suppressors p53 and p27 determines cisplatin sensitivity and limits the effectiveness of an IGF-1R pathway inhibitor.
    Davaadelger B; Duan L; Perez RE; Gitelis S; Maki CG
    Oncotarget; 2016 May; 7(19):27511-26. PubMed ID: 27050276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of cinobufagin on apoptosis in U-2OS osteosarcomas cells].
    Cao F; Kang X; Wang L
    Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2014 Mar; 28(3):349-53. PubMed ID: 24844018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oleandrin sensitizes human osteosarcoma cells to cisplatin by preventing degradation of the copper transporter 1.
    Yong L; Ma Y; Liang C; He G; Zhao Z; Yang C; Hai B; Pan X; Liu Z; Liu X
    Phytother Res; 2019 Jul; 33(7):1837-1850. PubMed ID: 31050072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syndecan-2 affects the basal and chemotherapy-induced apoptosis in osteosarcoma.
    Orosco A; Fromigué O; Bazille C; Entz-Werle N; Levillain P; Marie PJ; Modrowski D
    Cancer Res; 2007 Apr; 67(8):3708-15. PubMed ID: 17440083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
    Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
    PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mxd1 mediates hypoxia-induced cisplatin resistance in osteosarcoma cells by repression of the PTEN tumor suppressor gene.
    Zheng D; Wu W; Dong N; Jiang X; Xu J; Zhan X; Zhang Z; Hu Z
    Mol Carcinog; 2017 Oct; 56(10):2234-2244. PubMed ID: 28543796
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway.
    Zhang F; Yu X; Liu X; Zhou T; Nie T; Cheng M; Liu H; Dai M; Zhang B
    Oncol Rep; 2017 Oct; 38(4):2301-2308. PubMed ID: 28849162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Xiao Jin Wan, a traditional Chinese herbal formula, inhibits proliferation via arresting cell cycle progression at the G2/M phase and promoting apoptosis via activating the mitochondrial‑dependent pathway in U-2OS human osteosarcoma cells.
    Wu G; Chu J; Huang Z; Ye J; Chen P; Zheng C; Li X; Liu X; Wu M
    Int J Oncol; 2013 Mar; 42(3):1070-80. PubMed ID: 23354363
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Secreted clusterin (sCLU) regulates cell proliferation and chemosensitivity to cisplatin by modulating ERK1/2 signals in human osteosarcoma cells.
    Huang H; Wang L; Li M; Wang X; Zhang L
    World J Surg Oncol; 2014 Aug; 12():255. PubMed ID: 25106434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mevalonate pathway inhibitors affect anticancer drug-induced cell death and DNA damage response of human sarcoma cells.
    Nilsson S; Huelsenbeck J; Fritz G
    Cancer Lett; 2011 May; 304(1):60-9. PubMed ID: 21356574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long non-coding RNA LINC00161 sensitises osteosarcoma cells to cisplatin-induced apoptosis by regulating the miR-645-IFIT2 axis.
    Wang Y; Zhang L; Zheng X; Zhong W; Tian X; Yin B; Tian K; Zhang W
    Cancer Lett; 2016 Nov; 382(2):137-146. PubMed ID: 27609068
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mdm2 antagonists induce apoptosis and synergize with cisplatin overcoming chemoresistance in TP53 wild-type ovarian cancer cells.
    Mir R; Tortosa A; Martinez-Soler F; Vidal A; Condom E; Pérez-Perarnau A; Ruiz-Larroya T; Gil J; Giménez-Bonafé P
    Int J Cancer; 2013 Apr; 132(7):1525-36. PubMed ID: 22961628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effect and mechanism of quercetin on proliferation and apoptosis of human osteosarcoma cell U-2OS/MTX300].
    Yin J; Xie X; Jia Q; Wang J; Huang G; Zou C; Shen J
    Zhongguo Zhong Yao Za Zhi; 2012 Mar; 37(5):611-4. PubMed ID: 22693904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.